Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-14 Purchase |
2021-09-15 8:00 pm |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
50,000 | $1.13 | $56,500 | 226,875 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 9:08 pm |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
777 | $1.2 | $932 | 19,273 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 9:07 pm |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
1,125 | $1.2 | $1,350 | 21,725 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 9:06 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
531 | $1.2 | $637 | 41,862 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 9:05 pm |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
777 | $1.2 | $932 | 23,773 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 9:04 pm |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
777 | $1.2 | $932 | 18,473 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-06 Tax Withholding |
2021-11-09 5:36 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.33 | 366,351 (Direct) |
View |
| 2021-10-31 Tax Withholding |
2021-11-01 7:51 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.15 | 226,436 (Direct) |
View |
| 2021-10-31 Tax Withholding |
2021-11-01 7:50 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.15 | 366,443 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 6:10 pm |
N/A 2031-10-28 |
Nabriva Therapeutics plc | NBRV | Guico-Pabia Christine J. Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-10-06 Tax Withholding |
2021-10-08 4:41 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.08 | 366,506 (Direct) |
View |
| 2021-10-06 Tax Withholding |
2021-10-08 4:39 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.08 | 226,543 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-04 4:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.19 | 226,768 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-04 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.19 | 366,598 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:06 pm |
N/A 2031-09-29 |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-09-06 Tax Withholding |
2021-09-08 5:27 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.11 | 176,875 (Direct) |
View |
| 2021-09-06 Tax Withholding |
2021-09-08 5:25 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
93 | $1.11 | 366,661 (Direct) |
View |
| 2021-08-31 Tax Withholding |
2021-09-02 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.06 | 366,754 (Direct) |
View |
| 2021-08-31 Tax Withholding |
2021-09-02 4:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.06 | 177,100 (Direct) |
View |
| 2021-08-31 Tax Withholding |
2021-09-02 4:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.06 | 41,194 (Direct) |
View |
| 2021-08-06 Tax Withholding |
2021-08-10 5:16 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.17 | 177,207 (Direct) |
View |
| 2021-08-06 Tax Withholding |
2021-08-10 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.17 | 366,817 (Direct) |
View |
| 2021-08-06 Tax Withholding |
2021-08-10 5:13 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
74 | $1.17 | 41,231 (Direct) |
View |
| 2021-07-31 Tax Withholding |
2021-08-03 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.1 | 177,432 (Direct) |
View |
| 2021-07-31 Tax Withholding |
2021-08-03 4:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.1 | 366,909 (Direct) |
View |
| 2021-07-31 Tax Withholding |
2021-08-03 4:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $1.1 | 41,305 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:23 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
52,500 | $0 | 57,850 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:22 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
52,500 | $0 | 77,393 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:21 pm |
N/A 2031-07-28 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
52,500 | $0 | 59,550 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:20 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
52,500 | $0 | 54,250 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:19 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
52,500 | $0 | 55,050 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:18 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director |
52,500 | $0 | 52,500 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 8:17 pm |
N/A 2031-07-27 |
Nabriva Therapeutics plc | NBRV | Dalton Lisa Director |
53,000 | $0 | 53,000 (Direct) |
View |
| 2021-07-06 Tax Withholding |
2021-07-08 4:11 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.27 | 177,539 (Direct) |
View |
| 2021-07-06 Tax Withholding |
2021-07-08 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $1.27 | 366,972 (Direct) |
View |
| 2021-07-06 Tax Withholding |
2021-07-08 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
74 | $1.27 | 41,342 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $1.35 | 177,764 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:05 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $1.35 | 367,064 (Direct) |
View |